Cancer Biomarkers Market to Grow at 13.2% CAGR from 2022 to 2030

Berlinhopkin21 Sep, 2022Other

However, the high cost of treatment and unfavorable reimbursement policies by the government is hindering the growth of the market. The diagnosis and treatment of cancer are costly compared to other diseases as it includes medical and non-medical costs for diagnosis, treatment, and post-operative care. The rising need for personalized medicines for cancer treatment is a lucrative opportunity for the market's growth. However, the complicated sample collection procedure is still challenging for the cancer biomarkers market.